FREQUENCY OF NEPHROTIC SYNDROME AMONG DIABETES MELLITUS PATIENTS PRESENTING WITH PROTEINURIA AT SAIDU GROUP OF TEACHING HOSPITAL

J ALI; MA KHAN

doi:10.54112/pjicm.v5i02.182

Authors

J ALI Department of General Medicine, Saidu Group of Teaching Hospitals, Swat, Pakistan
MA KHAN Department of General Medicine, Saidu Group of Teaching Hospitals, Swat, Pakistan

DOI:

https://doi.org/10.54112/pjicm.v5i02.182

Keywords:

Diabetic Nephropathy, Nephrotic Syndrome, Proteinuria, Hypoalbuminemia

Abstract

Background: Diabetes mellitus is a leading cause of chronic kidney disease worldwide, often presenting with proteinuria as an early indicator of renal involvement. However, the occurrence of nephrotic syndrome in diabetic patients with proteinuria varies and carries important clinical implications for disease management and prognosis. Objective: To determine the frequency of nephrotic syndrome among diabetes mellitus patients presenting with proteinuria at Saidu Group of Teaching Hospitals (SGTH), Swat. Study Design: Cross-sectional study. Setting: Department of Medicine, Saidu Group of Teaching Hospitals (SGTH), Swat, Pakistan. Duration of Study: From 29-11-2024 to 29-05-2025. Methods: A total of 189 patients aged 30–70 years with confirmed diabetes mellitus and proteinuria were enrolled. Nephrotic syndrome was defined as a urine protein-to-creatinine ratio (uPCR) ≥200 mg/mmol and serum albumin ≤2.5 mg/L. Demographic data, comorbidities, and biochemical findings were recorded. Statistical analysis was performed using SPSS version 23, and associations were evaluated using the Chi-square test with a significance threshold of p < 0.05. Results: The mean age of participants was 57 ± 11 years, with a male predominance (118; 62.4%). Hypertension was observed in 117 (61.9%) patients. Nephrotic syndrome was identified in 88 (46.6%) of the study participants. A significant association was found between hypertension and nephrotic syndrome (p = 0.001). Conclusion: Nephrotic syndrome was highly prevalent among diabetic patients presenting with proteinuria in this study. The strong association with hypertension underscores the need for early screening and integrated management of renal and cardiovascular risks in diabetic populations.

References

Ahmad E, Lim S, Lamptey R, Webb DR, Davies MJ. Type 2 diabetes. Lancet. 2022;400(10365):1803–20. https://doi.org/10.1016/S0140-6736(22)01655-5

Quattrin T, Mastrandrea LD, Walker LS. Type 1 diabetes. Lancet. 2023;401(10394):2149–62. https://doi.org/10.1016/S0140-6736(23)00223-4

González P, Lozano P, Ros G, Solano F. Hyperglycemia and oxidative stress: an integral, updated and critical overview of their metabolic interconnections. Int J Mol Sci. 2023;24(11):9352. https://doi.org/10.3390/ijms24119352

Powers MA, Bardsley J, Cypress M, Duker P, Funnell MM, Fischl AH, et al. Diabetes self-management education and support in type 2 diabetes: a joint position statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics. Diabetes Educ. 2017;43(1):40–53. https://doi.org/10.1177/0145721716689694

Heyman SN, Raz I, Dwyer JP, Weinberg Sibony R, Lewis JB, Abassi Z. Diabetic proteinuria revisited: updated physiologic perspectives. Cells. 2022;11(18):2917. https://doi.org/10.3390/cells11182917

Jeerasuwannakul B, Sawunyavisuth B, Khamsai S, Sawanyawisuth K. Prevalence and risk factors of proteinuria in patients with type 2 diabetes mellitus. Asia Pac J Sci Technol. 2021;26(4):APST-26. https://doi.org/10.14456/apst.2021.32

Liu P, Zhang J, Wang Y, Shen Z, Wang C, Chen DQ, et al. The active compounds and therapeutic target of Tripterygium wilfordii Hook f. in attenuating proteinuria in diabetic nephropathy: a review. Front Med (Lausanne). 2021;8:747922. https://doi.org/10.3389/fmed.2021.747922

Politano SA, Colbert GB, Hamiduzzaman N. Nephrotic syndrome. Prim Care. 2020;47(4):597–613. https://doi.org/10.1016/j.pop.2020.08.002

Gordon-Cappitelli J, Choi MJ. Prophylactic anticoagulation in adult patients with nephrotic syndrome. Clin J Am Soc Nephrol. 2020;15(1):123–5. https://doi.org/10.2215/CJN.05250419

Masood A, Ujala S, Ali SA. Incidence of nephrotic syndrome in type 2 diabetic patients presenting with proteinuria. RADS J Pharm Pharmaceut Sci. 2021;9(4):208–13.

Sharma M, Parry MA, Jeelani H, Mahanta PJ, Doley PK, Pegu G. Prevalence of nondiabetic renal disease in patients with type 2 diabetes mellitus with clinicopathological correlation: a study from a tertiary care center of Assam, India. Saudi J Kidney Dis Transpl. 2020;31(4):831–9.

Al-Shammakh AA, Ali AD, Al Jermozy H. Prevalence of proteinuria among type 2 diabetic patients in Dhamar Governorate, Yemen. Int J Diabetes Clin Res. 2019;6:106. https://doi.org/10.23937/2377-3634/1410106

Najam-ud-Din, Khan AZ, Shah SJH, Anwar N, Hakeem F. Clinical presentations of nephrotic syndrome in patients of a tertiary care hospital at Peshawar. J Ayub Med Coll Abbottabad. 2013;25(3–4):31–4.

Stoycheff N, Stevens LA, Schmid C, Tighiouart H, Lewis J, Atkins RC, et al. Nephrotic syndrome in diabetic kidney disease: an evaluation and update of the definition. Am J Kidney Dis. 2009;54(5):840–9. https://doi.org/10.1053/j.ajkd.2009.04.016

Ruggenenti P, Kraus BJ, Inzucchi SE, Zinman B, Hantel S, Mattheus M, et al. Nephrotic-range proteinuria in type 2 diabetes: effects of empagliflozin on kidney disease progression and clinical outcomes. eClinicalMedicine. 2022;43:101240. https://doi.org/10.1016/j.eclinm.2021.101240